Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential versus standard triple therapy for Helicobacter pylori eradication in China
ACTRN12613000377730Phase 3Completed
- Sponsor
- Sanren Lin
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of esomeprazole, amoxicillin, clarithromycin and tinidazole in Helicobacter pylori infection (2 arms), sponsored by Sanren Lin. Primary endpoint: Helicobacter pylori eradication rate. Started Mar 2008; status: completed.
02
Drugs
esomeprazoleamoxicillinclarithromycintinidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ACTRN12613000377730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000377730.